BioHealth News Archive
Bio: Congressional commission urges support in U.S.-China competition for biotech dominance
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into…
Read More
TEDCO Invests in Neuros Biotechnology
COLUMBIA, Md., (April 14, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $25,000 Pre-Seed Rural Business Innovation Initiative (RBII) investment in Neuros…
Read More
AI for Smart Manufacturing: University of Maryland to Host High-Impact Forum on Industrial Productivity
The Maryland Department of Commerce, in collaboration with the University of Maryland, College Park, is hosting the AI for Smart Manufacturing Productivity Forum on…
Read More
BHI Joins Regional Leaders at the Inaugural BioConnect Event in North Bethesda
BioHealth Innovation, Inc. (BHI) was proud to join innovators, resource partners, and public officials at the first-ever BioConnect event—a new platform designed to foster…
Read More
U.Va. hires AstraZeneca exec to lead Manning biotech institute
by Kate Andrews - Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader…
Read More
I95 Business: Tammi Thomas: A Driving Force for Growth in Maryland
By Alex Keown - Tammi Thomas is a proponent of agape love, a selfless form of unconditional love that puts the needs of others first.…
Read More
BHI EIRs Engage at the 2025 Maryland MedTech Summit: A Full-Day Showcase of Innovation and Opportunity
On April 8, 2025, the Maryland MedTech Summit convened nearly 370 leaders from across the medical technology ecosystem at the University of Maryland, College…
Read More
Sixty Degrees Pharma Licenses Yale Patents to Develop Tafenoquine for Babesiosis
WASHINGTON, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing…
Read More
Georgetown Showcases Innovation and Impact at First-Ever Research & Innovation Showcase
On April 1st, Georgetown University celebrated a landmark moment in its growing innovation ecosystem with a full-day dedicated to advancing research, entrepreneurship, and industry…
Read More
United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work®…
Read More
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of…
Read More
Boost Your Summer Team with Top Talent: UMD Smith School’s Graduate Internship Program Offers $1,500 Reimbursement Per Intern
This summer, your business can tap into Maryland’s top graduate business talent and get rewarded for it. The Maximizing Maryland Graduate Internship Program, run…
Read More
Save the Date & Sponsor the Future: BioHealth Capital Region Week Returns September 23–25, 2025
Mark your calendars! The 11th Annual BioHealth Capital Region Forum will return September 23rd–24th, 2025, once again hosted at US Pharmacopeia (USP) in Rockville,…
Read More
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
ASHBURN, Va., April 02, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company…
Read More
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of MIND Institute
POTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating…
Read More